Hynnova’s machine learning applications are currently being deployed to streamline home care activities and Covid-19 vaccination campaigns in the northern area of the Italian city.
ASL Torino 4, the local public health company serving the Italian Metropolitan city of Turin’s northern area, has signed a deal with Hynnova to deploy its products to help streamline home care activities and Covid-19 vaccination programmes.
Hynnova, a start-up launched within the EIT Digital Innovation Factory, developed a platform that uses advanced mathematics and machine learning to dynamically optimise the use of healthcare spaces and resources.
As part of the contract, ASL Torino 4 will use both Hynnova solutions: ASC Home Healthcare to manage its day-to-day home assistance and care activities operations; and ASC Smart Booking to optimise the local vaccination campaign for the 520,000 citizens it serves.
The platform integrates information coming from three separate datasets:
It then generates optimised work-programmes and optimal paths, maximising the time spent on productive activities and minimising downtime, the company reports.
According to Hynnova, its mission is particularly relevant in the current context with the spread of Covid-19 pushing healthcare systems to operate as much as possible in a decentralised manner.
The solution allocates available resources in the “best possible way” and is specifically tailored to address the specific constraints of vaccination campaigns
In addition, the start-up points out its goal is consistent with the World Health Organisation’s guidelines on the Ageing Society, that advocate a gradual transition from a centralised care model (hospital and nursing homes) to a decentralised one.
Hynnova is one of the activities selected by the EIT Digital Innovation Factory in mid-2020 within Data Against Covid-19 initiative, an effort to develop digital tools to fight back against the pandemic in less than six months. With the support of EIT Digital, the Hynnova start-up was launched by Italian company Hypermynds and the Dutch Kinetic Analysis.
Vivisol, one of the main European groups operating in home care, was Hynnova’s first customer, purchasing from Hynnova in December 2020. In the meantime, Hynnova developed the ASC Smart Booking solution, to help manage and optimise vaccination campaigns.
Hynnova claims the solution allocates available resources in the “best possible way” and is specifically tailored to address the specific constraints of vaccination campaigns.
The company reports it is discussing possible deals with several other Italian local public health companies of which there are 110. “If just a few of these deals are finalised, we will become profitable, skipping the seed phase, and scaling the company,” Luca Calvetti, founder and chairman of Hypermynds, and CEO of Hynnova.
You might also like: